Mark J. Alles - 24 May 2021 Form 4 Insider Report for Turning Point Therapeutics, Inc.

Role
Director
Signature
/s/ Annette North, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
24 May 2021
Net transactions value
$0
Form type
4
Filing time
26 May 2021, 16:50:23 UTC
Next filing
04 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPTX Stock Option (right to buy) Award $0 +17,000 $0.000000 17,000 24 May 2021 Common Stock 17,000 $70.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in a series of 36 successive equal monthly installments over the three-year period measured from the date of grant.